Mediomics Lands $460K STTR Grant | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Mediomics has reeled in $460,000 from the National Institute of General Medical Sciences through a Phase II Small Business Technology Transfer (STTR) grant.

The company plans to use the funds to develop and increase the sensitivity of its biosensor technology and to develop its PINCER protein assay. Mediomics is commercializing core technologies it has licensed under an exclusive agreement with Saint Louis University.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.

In Science this week: new chromatin imaging approach, and more.